Raleigh company launches virtual, mobile clinical platform

A global contract research organization with headquarters in Raleigh has developed what it describes as the “first-ever completely virtual” clinical trial for drug indication. In fact, PRA Health Sciences announced that Janssen Pharmaceutical Companies of Johnson & Johnson is using the mobile clinical platform to launch a clinical trial assessing the effectiveness of of INVOKANA® (canagliflozin) in adults with heart failure with or without type 2 diabetes. Click here to learn more.


Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.